Latest Lead News

Catalina Resources has reported encouraging gold assay results from its recent diamond drilling at the Rock Lodge Project in NSW, highlighting significant mineralization zones that warrant further exploration.

Acusensus has secured major contract expansions across Australia and New Zealand, driving a 15.8% revenue increase in Q2 FY25 and bolstering its cash reserves to $30.3 million. The company’s strategic international push and innovative enforcement technologies position it for sustained growth.

Adriatic Metals delivered a strong Q4 2024 with 934koz silver equivalent produced, setting the stage for commercial production at Rupice Mine in Q1 2025. The company’s financial footing and expansion plans signal confidence in scaling operations.

Adriatic Metals has transitioned from development to production, delivering strong silver equivalent output in Q4 2024 despite extreme weather disruptions, and has updated its 2025 guidance with ambitious expansion plans.

Zeus Resources Ltd has successfully reinstated its securities on the ASX and raised over $1.2 million through a Share Purchase Plan, Priority Options Offer, and Placement, advancing exploration in uranium, lithium, and rare earth projects across South Australia and Western Australia.

Stavely Minerals reported a $1.593 million net cash outflow for Q4 2024 but plans to reduce exploration expenditure in the coming quarter to preserve its $2.673 million cash balance.

BauMart Holdings reports meaningful progress in expanding its distribution networks and strategic collaborations during the December 2024 quarter, positioning itself for growth across Indonesia, Australia, and the mining sector.

Euroz Hartleys Group reports a striking 501% jump in net profit for H1 FY2025, driven by strong capital raising and diversified revenue streams, prompting a dividend increase to 2 cents per share.

Tissue Repair Limited has commenced patient randomisation in its Phase 3 trial of TR987®, targeting chronic venous leg ulcers, aiming to confirm promising earlier results and potentially transform wound healing treatment.

JPMorgan Asset Management has announced estimated cash distributions for its suite of equity premium income ETFs for February 2025, providing investors with key dates and payout expectations.

Opyl Limited's Q2 FY25 update reveals robust progress through key partnerships, a new AI Biotech Fund launch, and strengthened financial footing, positioning the company for expanded influence in clinical trial optimisation.

ADX Energy reported steady production with 218 BOEPD and A$2.3 million revenue in Q4 2024, while progressing exploration in Austria and securing a new gas permit offshore Italy.